ArticleAnnals of hematology2024

Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial.

Huixing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.